Kidney Cancer Trial, Recruiting (NCT07038733)

Kidney Cancer Trial, Recruiting NCT07038733 Sponsor: Yale University Condition: Kidney Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT07038733 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Kidney Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are an adult (18 or older) who has been diagnosed with kidney cancer or is suspected of having kidney cancer
You have been referred to Yale Genitourinary Oncology providers in the Urology, Medical Oncology, Radiation Oncology, or Nephrology departments at Yale
You are receiving care, treatment, surgery, or other medical procedures at Yale New Haven Hospital or Smilow Cancer Hospital
You have a growth or mass on your kidney that is being evaluated

Who may not be able to join:

Anyone under the age of 18, as children are not being enrolled in this study
Anyone who is currently pregnant or breastfeeding
Anyone who has a known allergy or sensitivity to iodine

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 19 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: David Braun, MD, Yale University

Phone: 954-895-0576

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07038733

Sponsor: Yale University

Phase: Not Applicable

Status: Recruiting

Condition: Kidney Cancer

Trial contact: 954-895-0576

More information: https://clinicaltrials.gov/study/NCT07038733

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are an adult (18 or older) who has been diagnosed with kidney cancer or is suspected of having kidney cancer
You have been referred to Yale Genitourinary Oncology providers in the Urology, Medical Oncology, Radiation Oncology, or Nephrology departments at Yale
You are receiving care, treatment, surgery, or other medical procedures at Yale New Haven Hospital or Smilow Cancer Hospital
You have a growth or mass on your kidney that is being evaluated

Who may not be able to join:

Anyone under the age of 18, as children are not being enrolled in this study
Anyone who is currently pregnant or breastfeeding
Anyone who has a known allergy or sensitivity to iodine

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 19 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Yale University

Registry

ClinicalTrials.gov

Start date

30 January 2026

Est. completion

1 December 2030

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Molecular Profiling of Tumor and Draining Lymph Node Tissues in Kidney Cancer Patients; Molecular Responses to Anti-Cancer Therapies in Kidney Cancer Patients; Mechanistic Insights into Resistance to Anti-Cancer Therapies in Kidney Cancer; Biomarkers for Predicting Toxicities of Anti-Cancer Therapies in Kidney Cancer Patients

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov